{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:10:35Z","timestamp":1791774635196,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T00:00:00Z","timestamp":1397433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T00:00:00Z","timestamp":1397433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Disease activity, severity and comorbidity contribute to increased mortality in patients with rheumatoid arthritis (RA). We evaluated the impact of age at disease onset on prognostic risk factors and treatment in patients with early disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, 950 RA patients were followed regularly from the time of inclusion (&lt;12 months from symptom onset) for disease activity (erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tender and\/or swollen joints, Visual Analogue Scale pain and global scores, and Disease Activity Score in 28 joints (DAS28)) and function (Health Assessment Questionnaire (HAQ)). Disease severity, measured on the basis of radiographs of the hands and feet (erosions based on Larsen score), extraarticular disease, nodules, and comorbidities and treatment (disease-modifying antirheumatic drugs (DMARDs), corticosteroids, biologics and nonsteroidal anti-inflammatory drugs) were recorded at the time of inclusion and at 5 years. Autoantibodies (rheumatoid factor, antinuclear antibodies and antibodies against cyclic citrullinated peptides (ACPAs)) and genetic markers (human leucocyte antibody (HLA) shared epitope and protein tyrosine phosphatase nonreceptor type 22 (PTPN22)) were analysed at the time of inclusion. Data were stratified as young-onset RA (YORA) and late-onset RA (LORA), which were defined as being below or above the median age at the time of onset of RA (58 years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LORA was associated with lower frequency of ACPA (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05) and carriage of PTPN22-T variant (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01), but with greater disease activity at the time of inclusion measured on the basis of ESR (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), CRP (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01) and accumulated disease activity (area under the curve for DAS28 score) at 6 months (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01), 12 months (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01) and 24 months (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05), as well as a higher HAQ score (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01) compared with YORA patients. At baseline and 24 months, LORA was more often associated with erosions (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01 for both) and higher Larsen scores (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001 for both). LORA was more often treated with corticosteroids (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01) and less often with methotrexate (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) and biologics (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). YORA was more often associated with early DMARD treatment (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). The results of multiple regression analyses supported our findings regarding the impact of age on chosen treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>YORA patients were more frequently ACPA-positive than LORA patients. LORA was more often associated with erosions, higher Larsen scores, higher disease activity and higher HAQ scores at baseline. Nevertheless, YORA was treated earlier with DMARDs, whilst LORA was more often treated with corticosteroids and less often with DMARDs in early-stage disease. These findings could have implications for the development of comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/ar4540","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T05:01:49Z","timestamp":1397451709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study"],"prefix":"10.1186","volume":"16","author":[{"given":"Lena","family":"Innala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Berglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozena","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Ljung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgny","family":"Smedby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"S\u00f6dergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"W\u00e5llberg-Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,14]]},"reference":[{"key":"4265_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/art.10897","volume":"48","author":"EK Rasch","year":"2003","unstructured":"Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC: Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum. 2003, 48: 917-926. 10.1002\/art.10897.","journal-title":"Arthritis Rheum"},{"key":"4265_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/art.1780270805","volume":"27","author":"T Pincus","year":"1984","unstructured":"Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK: Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984, 27: 864-872. 10.1002\/art.1780270805.","journal-title":"Arthritis Rheum"},{"key":"4265_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","volume":"124","author":"A van der Heide","year":"1996","unstructured":"van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, Haanen HC, Hofman DM, van Albada-Kuipers GA, ter Borg EJ, Brus HL, Dinant HJ, Kruize AA, Schenk Y: The effectiveness of early treatment with \u201csecond-line\u201d antirheumatic drugs: a randomized, controlled trial. Ann Intern Med. 1996, 124: 699-707. 10.7326\/0003-4819-124-8-199604150-00001.","journal-title":"Ann Intern Med"},{"key":"4265_CR4","first-page":"445","volume":"24","author":"S Wallberg Jonsson","year":"1997","unstructured":"Wallberg Jonsson S, Ohman ML, Rantap\u00e4\u00e4-Dahlqvist S: Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol. 1997, 24: 445-451.","journal-title":"J Rheumatol"},{"key":"4265_CR5","first-page":"S35","volume":"26","author":"T Sokka","year":"2008","unstructured":"Sokka T, Abelson B, Pincus T: Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008, 26: S35-S61.","journal-title":"Clin Exp Rheumatol"},{"key":"4265_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.berh.2008.08.003","volume":"23","author":"T Sokka","year":"2009","unstructured":"Sokka T, M\u00e4kinen H: Drug management of early rheumatoid arthritis\u20142008. Best Pract Res Clin Rheumatol. 2009, 23: 93-102. 10.1016\/j.berh.2008.08.003.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4265_CR7","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D: Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008, 59: 1690-1697. 10.1002\/art.24092.","journal-title":"Arthritis Rheum"},{"key":"4265_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW: Rheumatoid arthritis. Lancet. 2010, 376: 1094-1108. 10.1016\/S0140-6736(10)60826-4.","journal-title":"Lancet"},{"key":"4265_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantap\u00e4\u00e4-Dahlqvist S: Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis. 2006, 65: 453-458. 10.1136\/ard.2005.041376.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S: Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007, 146: 797-808. 10.7326\/0003-4819-146-11-200706050-00008.","journal-title":"Ann Intern Med"},{"key":"4265_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/rheumatology\/38.3.228","volume":"38","author":"CT Pease","year":"1999","unstructured":"Pease CT, Bhakta BB, Devlin J, Emery P: Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology (Oxford). 1999, 38: 228-234. 10.1093\/rheumatology\/38.3.228.","journal-title":"Rheumatology (Oxford)"},{"key":"4265_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10067-004-1067-4","volume":"24","author":"J Calvo-Al\u00e9n","year":"2005","unstructured":"Calvo-Al\u00e9n J, Corrales A, S\u00e1nchez-Andrada S, Fern\u00e1ndez-Echevarr\u00eda MA, Pe\u00f1a JL, Rodr\u00edguez-Valverde V: Outcome of late-onset rheumatoid arthritis. Clin Rheumatol. 2005, 24: 485-489. 10.1007\/s10067-004-1067-4.","journal-title":"Clin Rheumatol"},{"key":"4265_CR13","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/ard.2005.051144","volume":"65","author":"Z Tutuncu","year":"2006","unstructured":"Tutuncu Z, Reed G, Kremer J, Kavanaugh A: Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?. Ann Rheum Dis. 2006, 65: 1226-1229. 10.1136\/ard.2005.051144.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/ard.2006.055657","volume":"66","author":"M Bukhari","year":"2007","unstructured":"Bukhari M, Lunt M, Barton A, Bunn D, Silman A, Symmons D: Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann Rheum Dis. 2007, 66: 389-393. 10.1136\/ard.2006.055657.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/kep129","volume":"48","author":"BJ Radovits","year":"2009","unstructured":"Radovits BJ, Fransen J, Eijsbouts A, van Riel PL, Laan RF: Missed opportunities in the treatment of elderly patients with rheumatoid arthritis. Rheumatology (Oxford). 2009, 48: 906-910. 10.1093\/rheumatology\/kep129.","journal-title":"Rheumatology (Oxford)"},{"key":"4265_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/rhe1.1957.3.issue-1-4.28","volume":"3","author":"M Oka","year":"1957","unstructured":"Oka M, Kytila J: Rheumatoid arthritis with the onset in old age. Acta Rheumatol Scand. 1957, 3: 249-258.","journal-title":"Acta Rheumatol Scand"},{"key":"4265_CR17","first-page":"607","volume":"2","author":"E Adler","year":"1966","unstructured":"Adler E: Rheumatoid arthritis in old age. Isr J Med Sci. 1966, 2: 607-613.","journal-title":"Isr J Med Sci"},{"key":"4265_CR18","first-page":"103","volume":"25","author":"GE Ehrlich","year":"1970","unstructured":"Ehrlich GE, Katz WA, Cohen SH: Rheumatoid arthritis in the aged. Geriatrics. 1970, 25: 103-113.","journal-title":"Geriatrics"},{"key":"4265_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/bmj.1.5905.444","volume":"1","author":"AB Corrigan","year":"1974","unstructured":"Corrigan AB, Robinson RG, Terenty TR, Dick-Smith JB, Walters D: Benign rheumatoid arthritis of the aged. Br Med J. 1974, 1: 444-446. 10.1136\/bmj.1.5905.444.","journal-title":"Br Med J"},{"key":"4265_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"4265_CR21","first-page":"157","volume":"2","author":"GF Ferraccioli","year":"1984","unstructured":"Ferraccioli GF, Cavalieri F, Mercadanti M, Conti G, Viviano P, Ambanelli U: Clinical features, scintiscan characteristics and X-ray progression of late onset rheumatoid arthritis. Clin Exp Rheumatol. 1984, 2: 157-161.","journal-title":"Clin Exp Rheumatol"},{"key":"4265_CR22","first-page":"1285","volume":"18","author":"DM van der Heijde","year":"1991","unstructured":"van der Heijde DM, van Riel PL, van Leeuwen MA, van \u2019t Hof MA, van Rijswijk MH, van de Putte LB: Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis. J Rheumatol. 1991, 18: 1285-1289.","journal-title":"J Rheumatol"},{"key":"4265_CR23","first-page":"2366","volume":"31","author":"HM Kremers","year":"2004","unstructured":"Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE: Therapeutic strategies in rheumatoid arthritis over a 40-year period. J Rheumatol. 2004, 31: 2366-2373.","journal-title":"J Rheumatol"},{"key":"4265_CR24","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/rheumatology\/kel144","volume":"45","author":"L Fraenkel","year":"2006","unstructured":"Fraenkel L, Rabidou N, Dhar R: Are rheumatologists' treatment decisions influenced by patients' age?. Rheumatology (Oxford). 2006, 45: 1555-1557. 10.1093\/rheumatology\/kel144.","journal-title":"Rheumatology (Oxford)"},{"key":"4265_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/art.22890","volume":"57","author":"G Schmajuk","year":"2007","unstructured":"Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH: Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum. 2007, 57: 928-934. 10.1002\/art.22890.","journal-title":"Arthritis Rheum"},{"key":"4265_CR26","volume-title":"Svensk Reumatologisk F\u00f6rening: Riktlinjer f\u00f6r L\u00e4kemedelsbehandling vid Reumatoid Artrit [120419]","author":"E Baecklund","year":"2012","unstructured":"Baecklund E, d\u2019Elia HF, Turesson C: Svensk Reumatologisk F\u00f6rening: Riktlinjer f\u00f6r L\u00e4kemedelsbehandling vid Reumatoid Artrit [120419]. 2012, G\u00f6teborg, Sweden: Svensk Reumatologisk F\u00f6rening, Available at http:\/\/www.svenskreumatologi.se\/riktlinjer (accessed 20 April 2014)"},{"key":"4265_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010, 69: 964-975. 10.1136\/ard.2009.126532.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR28","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/acr.21872","volume":"65","author":"JA Singh","year":"2013","unstructured":"Singh JA, Saag KG, Furst D: Reply to letter by Graudal and J\u00fcrgens. Arthritis Care Res (Hoboken). 2013, 65: 832-833.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4265_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/art.10135","volume":"46","author":"T M\u00f6tt\u00f6nen","year":"2002","unstructured":"M\u00f6tt\u00f6nen T, Hannonen P, Korpela M, Nissil\u00e4 M, Kautiainen H, Ilonen J, Laasonen L, Kaipiainen-Sepp\u00e4nen O, Franzen P, Helve T, Koski J, Gripenberg-Gahmberg M, Myllykangas-Luosuj\u00e4rvi R, Leirisalo-Repo M, FIN-RACo Trial Group (FINish Rheumatoid Arthritis Combination therapy): Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002, 46: 894-898. 10.1002\/art.10135.","journal-title":"Arthritis Rheum"},{"key":"4265_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0002-9343(01)00872-5","volume":"111","author":"LR Lard","year":"2001","unstructured":"Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, Hazes JM: Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001, 111: 446-451. 10.1016\/S0002-9343(01)00872-5.","journal-title":"Am J Med"},{"key":"4265_CR31","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1056\/NEJMra040226","volume":"350","author":"JR O'Dell","year":"2004","unstructured":"O'Dell JR: Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004, 350: 2591-2602. 10.1056\/NEJMra040226.","journal-title":"N Engl J Med"},{"key":"4265_CR32","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/art.20351","volume":"50","author":"M Korpela","year":"2004","unstructured":"Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Bl\u00e5field H, Puolakka K, M\u00f6tt\u00f6nen T: Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum. 2004, 50: 2072-2081. 10.1002\/art.20351.","journal-title":"Arthritis Rheum"},{"key":"4265_CR33","unstructured":"Svensk Reumatologis Kvalitetsregister (SRQ). Available at http:\/\/www.srq.nu (accessed 20 April 2014)."},{"key":"4265_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/03009748809098795","volume":"17","author":"C Ekdahl","year":"1988","unstructured":"Ekdahl C, Eberhardt K, Andersson SI, Svensson B: Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988, 17: 263-271. 10.3109\/03009748809098795.","journal-title":"Scand J Rheumatol"},{"key":"4265_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"key":"4265_CR36","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","volume":"41","author":"AM van Gestel","year":"1998","unstructured":"van Gestel AM, Haagsma CJ, van Riel PL: Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998, 41: 1845-1850. 10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K.","journal-title":"Arthritis Rheum"},{"key":"4265_CR37","doi-asserted-by":"publisher","first-page":"R303","DOI":"10.1186\/ar1187","volume":"6","author":"E Berglin","year":"2004","unstructured":"Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Rantap\u00e4\u00e4-Dahlqvist S: A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R303-R308. 10.1186\/ar1187.","journal-title":"Arthritis Res Ther"},{"key":"4265_CR38","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/ar1868","volume":"8","author":"M Johansson","year":"2006","unstructured":"Johansson M, \u00c4rlestig L, Hallmans G, Rantap\u00e4\u00e4-Dahlqvist S: PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther. 2006, 8: R19-10.1186\/ar1868.","journal-title":"Arthritis Res Ther"},{"key":"4265_CR39","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/ar2214","volume":"9","author":"H Kokkonen","year":"2007","unstructured":"Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S: The PTPN22 1858C\/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther. 2007, 9: R56-10.1186\/ar2214.","journal-title":"Arthritis Res Ther"},{"key":"4265_CR40","first-page":"1974","volume":"22","author":"A Larsen","year":"1995","unstructured":"Larsen A: How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol. 1995, 22: 1974-1975.","journal-title":"J Rheumatol"},{"key":"4265_CR41","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar3442","volume":"13","author":"L Innala","year":"2011","unstructured":"Innala L, M\u00f6ller B, Ljung L, Magnusson S, Smedby T, S\u00f6dergren A, Ohman ML, Rantap\u00e4\u00e4-Dahlqvist S, W\u00e5llberg-Jonsson S: Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011, 13: R131-10.1186\/ar3442.","journal-title":"Arthritis Res Ther"},{"key":"4265_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2006.052506","volume":"66","author":"C Turesson","year":"2007","unstructured":"Turesson C, McClelland RL, Christianson TJ, Matteson EL: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 70-75.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","volume":"300","author":"JN Matthews","year":"1990","unstructured":"Matthews JN, Altman DG, Campbell MJ, Royston P: Analysis of serial measurements in medical research. BMJ. 1990, 300: 230-235. 10.1136\/bmj.300.6719.230.","journal-title":"BMJ"},{"key":"4265_CR44","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/acr.20609","volume":"63","author":"EM Camacho","year":"2011","unstructured":"Camacho EM, Verstappen SMM, Lunt M, Bunn DK, Symmons DPM: Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken). 2011, 63: 1745-1752. 10.1002\/acr.20609.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4265_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/rheumatology\/keg077","volume":"42","author":"E Berglin","year":"2003","unstructured":"Berglin E, Lorentzon R, Nordmark L, Nilsson-Sojka B, Rantap\u00e4\u00e4-Dahlqvist S: Predictors of radiological progression and changes in hand bone density in early rheumatoid arthritis. Rheumatology (Oxford). 2003, 42: 268-275. 10.1093\/rheumatology\/keg077.","journal-title":"Rheumatology (Oxford)"},{"key":"4265_CR46","first-page":"CD006356","volume":"1","author":"JR Kirwan","year":"2007","unstructured":"Kirwan JR, Bijlsma JWJ, Boers M, Shea BJ: Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007, 1: CD006356-","journal-title":"Cochrane Database Syst Rev"},{"key":"4265_CR47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2008.087833","volume":"68","author":"I Hafstr\u00f6m","year":"2009","unstructured":"Hafstr\u00f6m I, Albertsson K, Boonen A, van der Heijde D, Landew\u00e9 R, Svensson B, BARFOT Study Group: Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann Rheum Dis. 2009, 68: 508-513. 10.1136\/ard.2008.087833.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR48","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/ard.2009.127332","volume":"69","author":"SL Gorter","year":"2010","unstructured":"Gorter SL, Bijlsma JW, Cutolo M, Gomez-Reino J, Kouloumas M, Smolen JS, Landew\u00e9 R: Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1010-1014. 10.1136\/ard.2009.127332.","journal-title":"Ann Rheum Dis"},{"key":"4265_CR49","first-page":"1632","volume":"27","author":"HE Paulus","year":"2000","unstructured":"Paulus HE, Di Primeo D, Sanda M, Lynch JM, Schwartz BA, Sharp JT, Genant HK, Weissman BN: Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis. J Rheumatol. 2000, 27: 1632-1637.","journal-title":"J Rheumatol"},{"key":"4265_CR50","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/11316740-000000000-00000","volume":"26","author":"JI Villa-Blanco","year":"2009","unstructured":"Villa-Blanco JI, Calvo-Al\u00e9n J: Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy. Drugs Aging. 2009, 26: 739-750. 10.2165\/11316740-000000000-00000.","journal-title":"Drugs Aging"},{"key":"4265_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","volume":"43","author":"JJ Anderson","year":"2000","unstructured":"Anderson JJ, Wells G, Verhoeven AC, Felson DT: Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000, 43: 22-29. 10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9.","journal-title":"Arthritis Rheum"},{"key":"4265_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rdc.2006.12.006","volume":"33","author":"Z Tutuncu","year":"2007","unstructured":"Tutuncu Z, Kavanaugh A: Rheumatic disease in the elderly: rheumatoid arthritis. Rheum Dis Clin North Am. 2007, 33: 57-70. 10.1016\/j.rdc.2006.12.006.","journal-title":"Rheum Dis Clin North Am"},{"key":"4265_CR53","first-page":"256","volume":"31","author":"D Huscher","year":"2013","unstructured":"Huscher D, Sengler C, Gromnica-Ihle E, Bischoff S, Eidner T, Ochs W, Richter J, Zink A: Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account. Clin Exp Rheumatol. 2013, 31: 256-262.","journal-title":"Clin Exp Rheumatol"},{"key":"4265_CR54","first-page":"691","volume":"30","author":"RM Fleischmann","year":"2003","unstructured":"Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT: Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results. J Rheumatol. 2003, 30: 691-696.","journal-title":"J Rheumatol"},{"key":"4265_CR55","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/art.22600","volume":"56","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH: Anti\u2013tumor necrosis factor \u03b1 therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007, 56: 1754-1764. 10.1002\/art.22600.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4540\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:15:49Z","timestamp":1728368149000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,14]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,4]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1186\/ar4540","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,14]]},"assertion":[{"value":"17 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R94"}}